Senior insider sale
Chief Medical Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$244.4K
4.18K shares
What this filing means
KENNEY CHRISTOPHER JOHN plans to sell 4.18K shares of XENON PHARMACEUTICALS INC. valued at approximately $244.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2026ACC: 0001193125-26-106682
Officer· Chief Medical Officer
Since Aug 2021
4.18K
Shares to sell
$244.4K
Approx. market value
3.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted share unit award vesting
N/A
3/12/2026
3.75KTotal acquired3.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2026 | Restricted share unit award vesting N/A | 3.75K | — |
| Total | 3.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.77K
Market value
$166.6K
3/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.41K
Market value
$77.9K
3/13/2026
Total
Units
4.18K
Value
$244.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 2.77K | $166.6K | — | Completed |
| Planned — Approximate Date | ||||
3/13/2026 | 1.41K | $77.9K | NASDAQ | Planned |
| Total | 4.18K | $244.4K | ||